A new study shows a product based on activated charcoal protects the gut microbiome in patients taking antibiotics. The Phase I clinical trial showed promising results. The study reported in the Journal of Infectious Diseases compared DAV132, with a placebo. “DAV132 was highly effective to protect the gut microbiome of moxafloxacin-treated healthy volunteers and may
Link Between Antibiotics and IBD Remains Circumstantial Effect stronger in children, and underscores need for antibiotic stewardship in prescribing for pediatric infections Since inflammatory bowel disease (IBD) is linked to disruption of the intestinal microbiome, antibiotics have come under increasing scrutiny as possible environmental catalysts in IBD – especially if taken in early childhood. So
